Final overall survival results show amivantamab plus lazertinib beat out osimertinib for first-line treatment of advanced ...

Compared to osimertinib, Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) significantly extended overall survival.

Johnson & Johnson's MARIPOSA study shows Rybrevant plus Lazcluze significantly extends overall survival in first-line ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL The combination of ...

Lung cancer is the leading cause of cancer deaths worldwide, mainly because it gets detected late. The discovery by the ...

Department of Chemistry, Wertheim UF Scripps, Jupiter, Florida 33418, United States The Skaggs Graduate School of Chemical and Biological Sciences, 120 Scripps Way, Jupiter, Florida 33458, United ...

UPDATE 3/6/2025 — All lanes of westbound I-44 near mile marker 95 have been reopened. UPDATE 8:20 PM – One lane of westbound I-44 near mile marker 95 has reopened. Delays are still expected on ...

The data will be presented at the American Academy of Dermatology (AAD) 2025 Annual Meeting, which takes place March 7-11, 2025, highlighting HT-001 as a potential breakthrough therapy for EGFR ...

CHECK THEY WERE LOOKING FOR OTHERS AND ALSO DEVELOPING. NOW, A MAN FROM MEEKER HAS DIED AFTER A CRASH OVERNIGHT. THIS HAPPENING NEAR I-44 IN RENO JUST BEFORE THREE THIS MORNING. OHP SAYS THAT A CAR ...